Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
New medicines: human
Get the latest updates from New medicines: human directly as they happen.
Follow now 578 followers
Latest posts
Last updated 4 days ago
Human medicines European public assessment report (EPAR): VaxRabeo, rabies vaccine (inactivated) for human, Status: Opinion
4 days ago
Human medicines European public assessment report (EPAR): VaxRabeo, rabies vaccine (inactivated) for...
Human medicines European public assessment report (EPAR): Zeydovio, glepaglutide, Status: Opinion
4 days ago
Human medicines European public assessment report (EPAR): Zeydovio, glepaglutide, Status: Opinion
Human medicines European public assessment report (EPAR): Sepalna, senaparib, Status: Opinion
4 days ago
Human medicines European public assessment report (EPAR): Sepalna, senaparib, Status: Opinion
Human medicines European public assessment report (EPAR): Ruxolitinib Zentiva, ruxolitinib, Status: Opinion
4 days ago
Human medicines European public assessment report (EPAR): Ruxolitinib Zentiva, ruxolitinib, Status: Opinion
Human medicines European public assessment report (EPAR): Povofortay, povorcitinib, Status: Opinion
4 days ago
Human medicines European public assessment report (EPAR): Povofortay, povorcitinib, Status: Opinion
Human medicines European public assessment report (EPAR): Pebrilzo, pertuzumab, Status: Opinion
4 days ago
Human medicines European public assessment report (EPAR): Pebrilzo, pertuzumab, Status: Opinion
Human medicines European public assessment report (EPAR): Lifyorli, relacorilant, Status: Opinion
4 days ago
Human medicines European public assessment report (EPAR): Lifyorli, relacorilant, Status: Opinion
Human medicines European public assessment report (EPAR): Inijaq, tofacitinib, Status: Opinion
4 days ago
Human medicines European public assessment report (EPAR): Inijaq, tofacitinib, Status: Opinion
Human medicines European public assessment report (EPAR): Frehemgo, denecimig, Status: Opinion
4 days ago
Human medicines European public assessment report (EPAR): Frehemgo, denecimig, Status: Opinion
Human medicines European public assessment report (EPAR): Adcomfo, omalizumab, Status: Opinion
4 days ago
Human medicines European public assessment report (EPAR): Adcomfo, omalizumab, Status: Opinion
Human medicines European public assessment report (EPAR): Ruxolitinib Viatris, ruxolitinib hemifumarate, Status: Opinion
2 months ago
Human medicines European public assessment report (EPAR): Ruxolitinib Viatris, ruxolitinib hemifumarate, Status...
Human medicines European public assessment report (EPAR): Susvimo, ranibizumab, Status: Opinion
about 2 months ago
Human medicines European public assessment report (EPAR): Susvimo, ranibizumab, Status: Opinion